Propofol Versus Dexmedetomidine for Prevention of Sevoflurane Agitation in Recipients of Living Donor Liver Transplantation

N/AUnknownNCT02544906

AlRefaey Kandeel120 enrolled

Overview

The use of propofol or dexmedetomedine for prevention of sevofurane emergence agitation in LDLT recipients

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

PREVENTION

Masking

SINGLE

Enrollment

120

Conditions

Liver Transplantation

Interventions

PropofolDRUG

Infusion of propofol to prevent emergence agitation in liver transplanta recipients

dexmedetomedineDRUG

Infusion of dexmedetomedine to prevent emergence agitation in liver transplanta recipients

Eligibility

Sex: ALLMin age: 30 YearsMax age: 60 Years

Medical Language ↔ Plain English

Inclusion Criteria: * All recipients of living donor liver transplantation Exclusion Criteria: * patient refusal Allergy to either propofol or dexmedetomediene CNS disease

Locations (1)

Mansoura university

Al Mansurah, Dkahleya, Egypt

Outcomes

Primary Outcomes

incidence of emergence agitation in liver trasnplant recipients

Time frame: 24 hours

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.